These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27699863)

  • 21. A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®
    Danese S; Hart A; Dignass A; Fiorino G; Louis E; Bonovas S; D'Haens G; Dotan I; Rogler G; Paridaens K; Peyrin-Biroulet L
    United European Gastroenterol J; 2019 Nov; 7(9):1171-1182. PubMed ID: 31700630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
    Naganuma M; Hirai F; Kobayashi K; Watanabe K; Takeuchi K; Aoyama N; Nozawa H; Motoya S; Ohmori T; Harada A; Nagai Y; Abe T; Yamada Y; Inagaki K; Shimizu N; Kanai T; Watanabe M;
    PLoS One; 2019; 14(8):e0220413. PubMed ID: 31381615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Chen X; Hou J; Yuan Y; Huang C; Liu T; Mo C; Li H; Chen B; Xu Q; Hou Z; He W; Liu F
    BioDrugs; 2016 Jun; 30(3):207-17. PubMed ID: 27120055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.
    Hoy SM
    Drugs; 2015 May; 75(8):879-86. PubMed ID: 25920500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis.
    Lichtenstein GR; Travis S; Danese S; D'Haens G; Moro L; Jones R; Huang M; Ballard ED; Bagin R; Hardiman Y; Collazo R; Sandborn WJ
    J Crohns Colitis; 2015 Sep; 9(9):738-46. PubMed ID: 26094251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
    Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
    Mosli MH; MacDonald JK; Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; Khanna R; Feagan BG
    Inflamm Bowel Dis; 2015 May; 21(5):1151-9. PubMed ID: 25844963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
    D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
    J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.
    Gross V; Bunganic I; Belousova EA; Mikhailova TL; Kupcinskas L; Kiudelis G; Tulassay Z; Gabalec L; Dorofeyev AE; Derova J; Dilger K; Greinwald R; Mueller R;
    J Crohns Colitis; 2011 Apr; 5(2):129-38. PubMed ID: 21453882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
    Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
    Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Battat R; Duijvestein M; Guizzetti L; Choudhary D; Boland BS; Dulai PS; Parker CE; Nguyen TM; Singh S; Vande Casteele N; Pai RK; Feagan BG; Sandborn WJ; Jairath V
    Am J Gastroenterol; 2019 May; 114(5):733-745. PubMed ID: 30694863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials.
    Zhang ZM; Li W; Jiang XL
    Gut Liver; 2016 Mar; 10(2):262-74. PubMed ID: 26780088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis.
    Stewart MJ; Seow CH; Storr MA
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):881-90. PubMed ID: 21699817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.
    Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB
    Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.
    Lichtenstein GR
    Dig Dis Sci; 2016 Feb; 61(2):358-70. PubMed ID: 26541989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
    Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
    Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.
    Danese S; Siegel CA; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2014 May; 39(10):1095-103. PubMed ID: 24641622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
    Sandborn WJ; Kamm MA; Lichtenstein GR; Lyne A; Butler T; Joseph RE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):205-15. PubMed ID: 17593066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.